Humacyte Inc (HUMA)
3.02 -0.29 (-8.89%) 11:41 ET [NASDAQ]
3.02 x 353 3.03 x 14
Realtime by (Cboe BZX)
3.02 x 353 3.03 x 14
Realtime 3.01 -0.31 (-9.34%) 09:29 ET
for Tue, Mar 25th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 80,448 | 149,772 | 217,502 | 39,929 | N/A |
Marketable Securities | N/A | 2,107 | 8,000 | N/A | N/A |
Receivables | N/A | 31 | 176 | 113 | N/A |
TOTAL | $83,278 | $154,208 | $229,340 | $41,449 | $N/A |
Non-Current Assets | |||||
PPE Net | 26,791 | 30,039 | 35,034 | 40,978 | N/A |
Other Non-Current Assets | 18,154 | 20,055 | 22,159 | 24,261 | 0 |
TOTAL | $44,945 | $50,094 | $57,193 | $65,239 | $N/A |
Total Assets | $128,223 | $204,302 | $286,533 | $106,688 | $N/A |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 6,490 | 1,595 | 2,094 | 2,274 | 0 |
Accrued Expenses | 9,340 | 7,108 | 6,757 | 4,592 | N/A |
TOTAL | $18,443 | $19,580 | $11,050 | $11,233 | $N/A |
Non-Current Liabilities | |||||
Long Term Debt | N/A | 20,336 | 27,361 | N/A | N/A |
aiOther Non-Current Liabilities | 79,941 | 28,605 | 104,839 | 422,538 | 0 |
TOTAL | $96,234 | $67,794 | $153,309 | $445,772 | $N/A |
Total Liabilities | $114,677 | $87,374 | $164,359 | $457,005 | $N/A |
Shareholders' Equity | |||||
Shares Outstanding, K | 119,084 | 103,329 | 103,005 | 12,855 | N/A |
Common Shares | 10 | 10 | 10 | 1 | N/A |
Retained earnings | -537,314 | -426,538 | -414,573 | -388,096 | N/A |
TOTAL | $13,546 | $116,928 | $122,174 | $-350,317 | $N/A |
Total Liabilities And Equity | $128,223 | $204,302 | $286,533 | $106,688 | $0 |